文献速递免疫规划传染病防控与疫情报告

鸭甲型肝炎病毒3型减毒活疫苗候选株SD70的研制

Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70).
PubMed 文献 · Vaccine · 2020-05-20

本研究旨在开发针对鸭甲型肝炎病毒3型(DHAV-3)的减毒活疫苗。将田间分离株SD在SPF鸡胚中连续传代致弱,第70代株SD70在鸡胚中病毒滴度为10^7.5 ELD50/mL,对1日龄鸭无临床致病性和死亡,经7次体内回归传代未出现毒力返强。SD70的最小有效剂量为10^2.5 ELD50(皮下接种),单剂即可对易感雏鸭提供良好的免疫保护。与亲本株SD相比,SD70基因组有12个氨基酸替换,部分可能参与毒力致弱。

要点

  • SD70株对1日龄鸭安全,无临床致病性和死亡,7次回归传代无毒力返强。
  • SD70最小有效剂量为10^2.5 ELD50,皮下接种单剂即可提供良好保护。
  • SD70鸡胚病毒滴度达10^7.5 ELD50/mL,生长能力良好。

核心结论

  • 减毒SD70株安全、稳定且保护效果优良,是预防DHAV-3感染的候选疫苗。

研究设计与样本

  • 将DHAV-3田间分离株SD在SPF鸡胚中连续传代致弱,筛选第70代株SD70作为减毒活疫苗候选株。

主要发现

  • SD70在鸡胚中病毒滴度为10^7.5 ELD50/mL。
  • SD70对1日龄鸭无临床致病性和死亡,经7次体内回归传代无毒力返强。
  • SD70最小有效剂量为10^2.5 ELD50(皮下接种),单剂对易感雏鸭提供良好保护。
  • 与亲本SD株相比,SD70基因组有12个氨基酸替换。

临床怎么用

  • SD70候选疫苗经皮下接种单剂10^2.5 ELD50即可对易感雏鸭提供保护,适用于DHAV-3防控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Duck hepatitis A virus type 3 (DHAV-3) is an important pathogen that causes substantial losses in the Chinese duck industry. DHAV-3 is highly fatal to ducklings and there is no licensed vaccine in China available to reduce DHAV-3 infection. Our goal was to develop a live attenuated vaccine candidate against DHAV-3. A field isolated strain, SD, was attenuated by serially passaging in specific-pathogen-free (SPF) chicken embryos, and it lost its pathogenicity after 40 passages. The 70th passaged strain (SD70), which achieved good growth capacity in chicken embryos with a viral titer of 107.5 ELD50/mL, was chosen to be the live attenuated vaccine candidate. The SD70 strain did not cause clinical signs of disease or mortality in 1-day-old ducklings and showed no virulence reversion after seven rounds of in vivo back passages. The minimum effective dose of SD70 was determined to be 102.5 ELD50 via the vaccination route of subcutaneous inoculation. A single dose of the SD70 provided good protection to susceptible ducklings against the lethal DHAV-3 strain. Compared with the genomic sequence of the parent SD strain, the SD70 had 12 amino acid substitutions, some of which may play a role in virulence attenuation. This study demonstrated that the attenuated SD70 strain is a promising vaccine candidate for the prevention of DHAV-3 infection in China. It exhibited safety, good stability and excellent protection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wu F, Lu F, Fan X, et al. Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70). Vaccine. 2020. PMID: 32446833. doi:10.1016/j.vaccine.2020.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。